The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for ...
Novartis today announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and ...
This milestone paves the way for broader access through public sector procurement and donor-funded programs, addressing a ...
The World Health Organization (WHO) on Friday announced that it has granted prequalification approval to a malaria treatment ...